Trials / Completed
CompletedNCT02620410
Treatment of REfractory Overactive BLadder With the AXonics Sacral Neuromodulation System (RELAX-OAB)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Axonics, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The RELAX-OAB (Treatment of REfractory Overactive BLadder with the AXonics Sacral Neuromodulation System) is a post-market clinical follow-up (PMCF) study designed to confirm the performance of the Axonics Sacral Neuromodulation (SNM) System as an aid in the treatment of the symptoms of overactive bladder (OAB) as well as capturing patient satisfaction and quality of life data.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Axonics Sacral Neuromodulation (SNM) System | The implantable components of the Axonics Sacral Neuromodulation (SNM) System consist of an IPG and tined lead. Additional components include a clinician programmer, surgical tool kit, recharging kit, and patient remote control. |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2017-06-01
- Completion
- 2022-01-01
- First posted
- 2015-12-03
- Last updated
- 2024-08-09
Locations
6 sites across 4 countries: Belgium, France, Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT02620410. Inclusion in this directory is not an endorsement.